Dialysis Market

Analysis by Type (Hemodialysis, and Peritoneal Dialysis); by Product and Service (Equipment, Consumables, Drugs, and Services), and by End-User (In-Center and Home Dialysis) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2033

Buy Now
Report ID: 4643 | Published On: Feb 15, 2023
Request Free Sample Copy

Global Dialysis Market Size, Forecast, and Trend Highlights Over 2023 – 2033

The global dialysis market is estimated to garner a revenue of ~USD 155 billion by the end of 2033 by growing at a CAGR of ~5% over the forecast period, i.e., 2023 – 2033. Further, the market generated a revenue of ~USD 110 billion in the year 2022. An increase in the prevalence of chronic kidney diseases, and a rise in the approval of new products are anticipated to boost the global dialysis market size during the forecast period. Moreover, there are an increasing number of patients suffering from chronic kidney disease is further projected to boost the market’s growth. As per the Centers for Disease Control and Prevention (CDC) greater than 1 in 7 adults, or 15% of the U.S adults, are estimated to have chronic kidney disease, i.e., about 37 million people in 2021.

Dialysis-Market-overview.jGet more information on this report:Download Sample PDF

Increasing healthcare infrastructure and growing research and development activities are estimated to drive the growth of the global dialysis market in the coming years.  The Centers for Medicare & Medicaid Services (CMS) declared the End-Stage Renal Disease (ESRD) Treatment Choices (ETC) Model to enhance and provide quality care by reducing the chronic kidney disease expenditure for patients of Medicare. In addition, it is estimated that the ETC model will save USD 23 million in five and a half years. Moreover, the growing number of awareness campaigns regarding the treatment efficacy of dialysis is anticipated to fuel the potential for market expansion over the forecast period.

Get more information on this report: Request Sample PDF

Global Dialysis Market: Key Insights

Base Year


Forecast Year




Base Year Market Size (2022)

~ USD 110 Billion

Forecast Year Market Size (2033)

~ USD 155 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of Middle East and Africa)

Global Dialysis Market: Growth Drivers and Challenges

Growth Drivers

  • Increasing Cases of Chronic Kidney Disease – Chronic kidney diseases or chronic kidney failure is the damage to the kidney to function normally. The damaged kidneys cannot filter blood to remove toxins. This will eventually lead to multi-organ damage, leading to hypertension, heart failure, a heart stroke, or death. Dialysis is one of the best options for treating chronic kidney disease, along with medical care. Moreover, unhealthy eating habits and the practice sedentary lifestyle make people more prone to kidney disease and are estimated to boost the market growth during the forecast period. As per the estimations, about 11% of the world’s population are suffering from chronic kidney disease in 2022.

  • Growing Prevalence of Diabetes Among the People – Diabetes affects every tissue, organ, and cell of the body, that increases the demand for dialysis among them. Hence, it is anticipated to surge the global dialysis market over the forecast period. As per the CDC, about 34.2 million people, or 10.5% of the population including all age groups, suffered from diabetes in the U.S in 2018.

  • Rising Reimbursement Policies for Renal Therapy – There has been an increase in reimbursement policies for renal disease treatment and other chronic diseases by the government, and it is expected to boost the market’s growth in the upcoming year. The U.S government paid USD 110 billion every year to treat chronic kidney disease and end-stage renal disease.
  • Increase in Renal Complications of Patients during COVID – As per the estimations, about 25% of global patients hospitalized with COVID-19 developed kidney injuries, and over 45% of patients with kidney injuries in the ICU (intensive care unit) needed dialysis

  • Rise in the Geriatric Population Across the World – There are higher chances among the aged population to be affected by the diseases, as the immunity gets weaken with age, and it is projected to drive the global dialysis market. As per the estimations, the number of old people across the world will double by 2050 and reach 2 billion up from 1.5 billion in 2030.


  • Rise in Kidney Transplantation – In the last decade, the number of live donor kidney transplants performed in the US and Canada has doubled and now represents just over 40% of all donor kidneys. Among deceased donor kidneys, the largest percentage increases were seen in expanded criteria donors and kidneys donated after cardiac death.
  • Rise in Cost of Renal Therapy followed by COVID
  • Lack of Awareness of Kidney Diseases

The global dialysis market is segmented and analyzed for demand and supply by type into hemodialysis, and peritoneal dialysis. Out of these, the hemodialysis segment is anticipated to hold the largest market size by the end of 2033 owing to the efficiency of dialysis to remove toxic materials and the rise of homecare adoption in end-stage renal disease and growing hypertension cases. As per the Centers for Disease Control and Prevention, over 670,000 deaths occurred owing to hypertension in the U.S in 2020. Hemodialysis is a process where blood is cleaned using a dialysis machine and a specific filter called an artificial kidney, or a dialyzer. The doctor must gain access to blood vessels in order to enter blood into the dialyzer. Minor surgery is used to accomplish this, typically on the arm. Hemodialysis can be carried out at home, in a hospital, or in a separate dialysis facility. A patient's doctor will pick the ideal location depending on the patient's medical needs and preferences.

The global dialysis market is also segmented and analyzed for demand and supply by end-user into in-center, and home dialysis. Amongst these two segments, the in-center segment is expected to garner a significant share. Patients needing dialysis often visit centers for treatment, and it is easier and convenient for them to have the treatment directly from the same hospital or center premises, where it was diagnosed. When a person receives their dialysis treatments in-center, they do it at a dialysis facility. When the kidneys are unable to do this task, dialysis is a procedure that removes wastes and excess fluid from the blood.

Our in-depth analysis of the global irritable bowel syndrome drugs market includes the following segments:

                By Type

  • Hemodialysis
  • Peritoneal Dialysis

              By Product and Service

  • Equipment
  • Consumables
  • Drugs
  • Services

                  By End-User

  • In-Center
  • Home Dialysis

Global Dialysis Market Regional Synopsis

The North America market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2033 on account of rising healthcare expenditure, and growing disposable income, and rising demand for the development of new products. The national health expenditure of the U.S. in 2020, rose by 9.7% and reached USD 4.1 trillion, or USD 12,350 for every person, as per the CMS. Further, the presence of a strong healthcare network in the region, along with the availability of supportive policies by the regulatory bodies that promote the market players to opt for investing into more research works to bring up more feasible solutions so as to develop efficient treatment options, are also anticipated to contribute to the market growth in the region.


Get more information on this report: Request Sample PDF

Top Featured Companies Dominating the Global Dialysis Market

    • Baxter International, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Nikkiso Co., Ltd.
    • NIPRO Corporation
    • Diaverum AB
    • B. Braun Melsungen AG
    • DaVita, Inc.
    • Asahi Kasei Corporation
    • NxStage Medical, Inc.
    • Fresenius Medical Care AG & Co. KGaA 



In The News

  • April 2022: IBSRELA the first and only NHE3 inhibitor for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults, has been made available by the biopharmaceutical company Ardelyx. The first Ardelyx product to receive approval from the US Food and Drug Administration is IBSRELA.
  • March 2022: Indegene a provider of technology-driven healthcare solutions, & meta Me Health, a maker of Regulora and a Prescription Digital Therapeutics (PDT) business, teamed up to offer Regulora as a remedy for irritable bowel syndrome-related stomach pain (IBS).

Global Economic Impact

Request Insights
Despite Inflation & Fearing Recession, Businesses Across the Globe Expected to Do Better in 2023:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.

Key Questions Answered in the Report

1) What are the major factors driving the growth of the dialysis market?

Ans: Increasing cases of chronic kidney disease and the growing prevalence of diabetes are the major factors driving the growth of the dialysis market.

2) What would be the CAGR of dialysis market over the forecast period?

Ans: The market is anticipated to attain a CAGR of ~5% over the forecast period, i.e., 2023 – 2033.

3) What are the challenges affecting the dialysis market growth?

Ans: The rise in kidney transplantation and the rise in the cost of renal therapy due to COVID are the challenges affecting the market growth.

4) Which region will provide more business opportunities for growth of dialysis market in future?

Ans: The market in North America region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

5) Who are the major players dominating the dialysis market?

Ans: The major players in the market are Baxter International, Inc., Nikkiso Co., Ltd., MEDIVATORS, Inc., NIPRO Corporation, Diaverum AB, B. Braun Melsungen AG, DaVita, Inc., Asahi Kasei Corporation, NxStage Medical, Inc., Fresenius Medical Care AG & Co. KGaA.

6) How are the company profiles selected?

Ans: The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determines the revenue-generating capacity as well as the new products being launched into the market by the company.

7) What are the segments in the dialysis market?

Ans: The market is segmented by type, product and service, end-user, and by region.

8) Which segment captures the largest market size in type in the dialysis market?

Ans: The hemodialysis segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

Request Research Report Sample